LAMTOR5 and breast carcinoma: As to Mettl3, hepatitis B X-interacting protein (HBXIP) can increase its expression in breast cancer cells via inhibiting miRNA let-7g, which downregulated the expression of Mettl3 by targeting its 3′UTR50.